Who
Natale S. Ricciardi
Director
Company insider
Files Form 4 as: Director, Rapid Micro Biosystems; Director, Prestige Consumer Healthcare; Director, Dynavax Technologies; Director, Asterias Biotherapeutics; Senior Vice President, Pfizer; Director, Mediacom Communications.
In numbers
- Trades disclosed
- 156
- Buys
- 3
- Sells
- 3
- Bought
- $183K
- Sold
- $895K
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 14 Mar 2006
- Last trade
- 27 Feb 2026
- Last filed
- 2 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Feb 2026filed 2 Mar 2026 | RPID Rapid Micro BiosystemsLife-science tools | SEC FORM 4 Code M | $632842 at $0.75 | filing |
| 27 Feb 2026filed 2 Mar 2026 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code M | $632842 at $0.75 | filing |
| 27 Feb 2026filed 2 Mar 2026 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code M | $632842 at $0.75 | filing |
| 27 Feb 2026filed 2 Mar 2026 | RPID Rapid Micro BiosystemsLife-science tools | SEC FORM 4 Code M | $632842 at $0.75 | filing |
| 22 May 2025filed 27 May 2025 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —28,650 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | RPID Rapid Micro BiosystemsLife-science tools | SEC FORM 4 Code A | —14,300 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —28,650 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | RPID Rapid Micro BiosystemsLife-science tools | SEC FORM 4 Code A | —14,300 at $0.00 | filing |
| 1 Aug 2023filed 3 Aug 2023 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,295 at $0.00 | filing |
| 4 May 2023filed 5 May 2023 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 2 Aug 2022filed 3 Aug 2022 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,495 at $0.00 | filing |
| 26 May 2022filed 27 May 2022 | Dynavax Technologiesoption or derivative | SEC FORM 4 Code A | —5,357 | filing |
| 26 May 2022filed 27 May 2022 | Dynavax Technologiesoption or derivative | SEC FORM 4 Code A | —22,500 | filing |
| 23 May 2022filed 10 Jun 2022 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —2,808 at $0.00 | filing |
| 14 Jul 2021filed 15 Jul 2021 | RPID Rapid Micro Biosystemsoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 28 May 2021filed 2 Jun 2021 | Dynavax Technologiesoption or derivative | SEC FORM 4 Code A | —25,000 | filing |
| 4 Aug 2020filed 6 Aug 2020 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —3,732 at $0.00 | filing |
| 28 May 2020filed 29 May 2020 | Dynavax Technologiesoption or derivative | SEC FORM 4 Code A | —25,000 | filing |
| 30 Jul 2019filed 1 Aug 2019 | PBH Prestige Consumer HealthcareHousehold & Personal Care | SEC FORM 4 Code A | —4,183 at $0.00 | filing |
News
Critical Analysis: Nexentis Technologies (NASDAQ:NXTS) versus Pfizer (NYSE:PFE)PFE · dailypolitical.com · 19 Oct 2026Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?PFE · fool.com · 19 Oct 2026Bristol Myers is Cheaper Than Pfizer, but Its 40% Earnings Jump Has a CatchPFE · insidermonkey.com · 19 Oct 2026Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings ResultsPBH · manilatimes.net · 14 Oct 2026
0 headlines in the last 90 days name Natale S. Ricciardi; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.